These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6034828)

  • 1. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.
    Aguiar AJ; Krc J; Kinkel AW; Samyn JC
    J Pharm Sci; 1967 Jul; 56(7):847-53. PubMed ID: 6034828
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension.
    Banerjee S; Bandyopadhyay A; Bhattacharjee RC; Mukherjee AK; Halder AK
    J Pharm Sci; 1971 Jan; 60(1):153-5. PubMed ID: 4994065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Far infrared and proton magnetic resonance spectra of chloramphenicol palmitate].
    Borka L
    Acta Pharm Hung; 1970 Jul; 40(4):150-5. PubMed ID: 4319041
    [No Abstract]   [Full Text] [Related]  

  • 4. IR spectroscopic studies of polymorphs of chloramphenicol palmitate.
    Borka L; Backe-Hansen K
    Acta Pharm Suec; 1968 Nov; 5(5):525-32. PubMed ID: 5732573
    [No Abstract]   [Full Text] [Related]  

  • 5. IR spectroscopy of chloramphenicol palmitate. Polymorph alteration caused by the KBr disc technique.
    Borka L; Backe-Hansen K
    Acta Pharm Suec; 1968 Sep; 5(4):271-8. PubMed ID: 5724369
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloramphenicol palmitate polymorphs. Differential thermal analysis and discussion of IR spectra.
    Borka L
    Acta Pharm Suec; 1970 Feb; 7(1):1-6. PubMed ID: 5450400
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloromycetin palmitate; observations on absorption, blood serum levels, and urinary excretion.
    YOW EM; TAYLOR FM; HIRSCH J; FRANKEL RA; CARNES HE
    J Pediatr; 1953 Feb; 42(2):151-6. PubMed ID: 13023513
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of rabbits for absorption studies on polymorphs of chloramphenicol palmitate.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):431-6. PubMed ID: 7389018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physicochemical properties and intestinal absorption of a ground mixture of chloramphenicol palmitate with microcrystalline cellulose (author's transl].
    Yamamoto K; Matsuda S; Nakano M; Arita T; Nakai Y
    Yakugaku Zasshi; 1977 Apr; 97(4):367-72. PubMed ID: 559740
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical applications of polymorphism.
    Haleblian J; McCrone W
    J Pharm Sci; 1969 Aug; 58(8):911-29. PubMed ID: 4899118
    [No Abstract]   [Full Text] [Related]  

  • 11. Surface electric charge of the active and inactive polymorphs of chloramphenicol palmitate.
    Kaliszan R
    J Pharm Sci; 1986 Feb; 75(2):187-9. PubMed ID: 3958931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid.
    Aguiar AJ; Zelmer JE
    J Pharm Sci; 1969 Aug; 58(8):983-7. PubMed ID: 5344535
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding.
    Otsuka M; Kaneniwa N
    J Pharm Sci; 1986 May; 75(5):506-11. PubMed ID: 3735092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
    Ambrose PJ
    Clin Pharmacokinet; 1984; 9(3):222-38. PubMed ID: 6375931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of increased rates of dissolution and oral absorption of chloramphenicol from chloramphenicol-urea solid dispersion system.
    Chiou WL
    J Pharm Sci; 1971 Sep; 60(9):1406-8. PubMed ID: 5567594
    [No Abstract]   [Full Text] [Related]  

  • 16. The monitoring of serum chloramphenicol levels in children with severe infections.
    Ekblad H; Ruuskanen O; Lindberg R; Iisalo E
    J Antimicrob Chemother; 1985 Apr; 15(4):489-94. PubMed ID: 4008381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymorphism of phenobarbitone.
    Mesley RJ; Clements RL; Flaherty B; Goodhead K
    J Pharm Pharmacol; 1968 May; 20(5):329-40. PubMed ID: 4385435
    [No Abstract]   [Full Text] [Related]  

  • 18. The polymorphism of sulphathiazole.
    Mesley RJ
    J Pharm Pharmacol; 1971 Sep; 23(9):687-94. PubMed ID: 4398247
    [No Abstract]   [Full Text] [Related]  

  • 19. Photodegradation products of chloramphenicol in aqueous solution.
    Shih IK
    J Pharm Sci; 1971 Dec; 60(12):1889-90. PubMed ID: 5158015
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential CSF concentration of chloramphenicol after administration of oral chloramphenicol palmitate.
    Rensimer ER; Pickering LK; Ericsson CD; Kramer WG
    Lancet; 1981 Jan; 1(8212):165. PubMed ID: 6109852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.